MIRM
Mirum Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite +8.3% ·
Aktienfluss +12.4% ·
neue Nettopositionen +7.7%
— Formel
Breite Akkumulation — steigende Anteile bei mehr Haltern
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q1 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 106 | +2 | 35.68M | $4.18B | +9 | −7 |
| Q1 2026 | 107 | +6 | 39.52M | $3.63B | +12 | −7 |
| Q4 2025 | 102 | +1 | 36.05M | $2.83B | +2 | — |
| Q3 2025 | 20 | 0 | 17.64M | $1.29B | — | — |
| Q2 2025 | 17 | +1 | 13.61M | $692.65M | +2 | −1 |
| Q1 2025 | 13 | +1 | 7.45M | $335.67M | +2 | −1 |
| Q4 2024 | 12 | 0 | 6.63M | $274.04M | +1 | −1 |
| Q3 2024 | 11 | +2 | 4.84M | $188.84M | +2 | — |
| Q2 2024 | 9 | — | 4.39M | $149.94M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passiv) | 1.49M | +8.2% | $67.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Citadel Advisors ✦ | 1.45M | -4.3% | $65.14M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 1.45M | -4.3% | $65.14M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 4 | Citadel Advisors ✦ | 1.45M | -4.3% | $65.14M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 1.42M | -0.5% | $63.75M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 1.42M | -0.5% | $63.75M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 7 | Geode Capital Management ✦ (passiv) | 963.66K | +2.1% | $43.42M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | Geode Capital Management ✦ (passiv) | 963.66K | +2.1% | $43.42M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | D. E. Shaw & Co. ✦ | 543.28K | +245.3% | $24.47M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 543.28K | +245.3% | $24.47M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Millennium Management ✦ | 479.30K | -9.1% | $21.59M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | Adage Capital Partners ✦ | 345.00K | +130.0% | $15.54M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 13 | Point72 Asset Management ✦ | 232.10K | Neu | $10.46M | 0.0% | New | 1 | SEC ↗ |
| 14 | Point72 Asset Management ✦ | 232.10K | Neu | $10.46M | 0.0% | New | 1 | SEC ↗ |
| 15 | Renaissance Technologies ✦ | 188.50K | +86.2% | $8.49M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 175.13K | +38.5% | $7.89M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 17 | Wellington Management ✦ | 112.92K | -4.5% | $5.09M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | Wellington Management ✦ | 112.92K | -4.5% | $5.09M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 19 | Wellington Management ✦ | 112.92K | -4.5% | $5.09M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 20 | Wellington Management ✦ | 112.92K | -4.5% | $5.09M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 49.08K | +307.3% | $2.21M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 49.08K | +307.3% | $2.21M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 49.08K | +307.3% | $2.21M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 49.08K | +307.3% | $2.21M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 49.08K | +307.3% | $2.21M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 26 | Gotham Asset Management ✦ | 6.04K | Neu | $272,237 | 0.0% | New | 1 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Point72 Asset Management | $10.46M | 0.0% |
| Point72 Asset Management | $10.46M | 0.0% |
| Gotham Asset Management | $272,237 | 0.0% |
Ausgestiegen
| Marshall Wace | $7.27M | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 308 Inhaber, 67.83M Anteile, $6.01B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.
Käufe auf dem offenen Markt (P)
Keine Insider-Käufe auf dem offenen Markt in unserem Erfassungszeitraum.
Verkäufe auf dem offenen Markt (S)
Officer · 40.00K Ant. · $4.00M
Officer · 6.00K Ant. · $599,510
Officer, Director · 11.68K Ant. · $1.15M
Officer, Director · 6.02K Ant. · $597,187
Officer, Director · 2.30K Ant. · $230,322
Zuteilungen, Ausübungen und Steuereinbehalte werden hier nie als Käufe oder Verkäufe gezählt. Methodik